195 related articles for article (PubMed ID: 30251395)
41. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.
Reynolds CP
Curr Oncol Rep; 2000 Nov; 2(6):511-8. PubMed ID: 11122886
[TBL] [Abstract][Full Text] [Related]
42. Correlation between transglutaminase activity and polyamine levels in human neuroblastoma cells. Effect of retinoic acid and alpha-difluoromethylornithine.
Melino G; Farrace MG; Ceru' MP; Piacentini M
Exp Cell Res; 1988 Dec; 179(2):429-45. PubMed ID: 2903830
[TBL] [Abstract][Full Text] [Related]
43. Reduced tissue ornithine increases the cytotoxicity of difluoromethylornithine.
Grossie VB; Nishioka K
Anticancer Res; 1996; 16(6B):3731-5. PubMed ID: 9042249
[TBL] [Abstract][Full Text] [Related]
44. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
45. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
[TBL] [Abstract][Full Text] [Related]
46. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
Alhonen-Hongisto L; Levin VA; Marton LJ
Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
[TBL] [Abstract][Full Text] [Related]
47. Effect of alpha-difluoromethylornithine on 1,3-bis(2-chloroethyl)-1-nitrosourea and cis-diamminedichloroplatinum(II) cytotoxicity, DNA interstrand cross-linking, and growth in human brain tumor cell lines in vitro.
Hunter KJ; Deen DF; Pellarin M; Marton LJ
Cancer Res; 1990 May; 50(9):2769-72. PubMed ID: 2109657
[TBL] [Abstract][Full Text] [Related]
48. Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide.
Reynolds CP; Wang Y; Melton LJ; Einhorn PA; Slamon DJ; Maurer BJ
Med Pediatr Oncol; 2000 Dec; 35(6):597-602. PubMed ID: 11107126
[TBL] [Abstract][Full Text] [Related]
49. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide.
Lovat PE; Di Sano F; Corazzari M; Fazi B; Donnorso RP; Pearson AD; Hall AG; Redfern CP; Piacentini M
J Natl Cancer Inst; 2004 Sep; 96(17):1288-99. PubMed ID: 15339967
[TBL] [Abstract][Full Text] [Related]
50. Fenretinide activates caspases and induces apoptosis in gliomas.
Puduvalli VK; Saito Y; Xu R; Kouraklis GP; Levin VA; Kyritsis AP
Clin Cancer Res; 1999 Aug; 5(8):2230-5. PubMed ID: 10473110
[TBL] [Abstract][Full Text] [Related]
51. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
Di Vinci A; Geido E; Infusini E; Giaretti W
Int J Cancer; 1994 Nov; 59(3):422-6. PubMed ID: 7927952
[TBL] [Abstract][Full Text] [Related]
52. In vivo enhancement of herpes simplex virus thymidine kinase/ganciclovir cancer gene therapy with polyamine biosynthesis inhibition.
Wahlfors T; Hakkarainen T; Jänne J; Alhonen L; Wahlfors J
Int J Cancer; 2006 Jun; 118(11):2907-10. PubMed ID: 16385565
[TBL] [Abstract][Full Text] [Related]
53. Endoplasmic Reticulum Stress is Involved in DFMO Attenuating Isoproterenol-Induced Cardiac Hypertrophy in Rats.
Lin Y; Zhang X; Xiao W; Li B; Wang J; Jin L; Lian J; Zhou L; Liu J
Cell Physiol Biochem; 2016; 38(4):1553-62. PubMed ID: 27074051
[TBL] [Abstract][Full Text] [Related]
54. Opposing effects of suramin and DL-alpha-difluoromethylornithine on polyamine metabolism contribute to a synergistic action on B16 melanoma cell growth in vitro.
Gritli-Linde A; Björkman U; Delle U; Hultborn R; Johansson BR; Nannmark U; Linde A
Anticancer Res; 1998; 18(2A):863-70. PubMed ID: 9615733
[TBL] [Abstract][Full Text] [Related]
55. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.
Merali S; Clarkson AB
Antimicrob Agents Chemother; 1996 Apr; 40(4):973-8. PubMed ID: 8849262
[TBL] [Abstract][Full Text] [Related]
56. Effects of DFMO-induced polyamine depletion on human tumor cell sensitivity to antineoplastic DNA-crosslinking drugs.
Seidenfeld J; Komar KA; Naujokas MF; Block AL
Cancer Chemother Pharmacol; 1986; 17(1):16-20. PubMed ID: 3084110
[TBL] [Abstract][Full Text] [Related]
57. Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro.
Takigawa M; Enomoto M; Nishida Y; Pan HO; Kinoshita A; Suzuki F
Cancer Res; 1990 Jul; 50(13):4131-8. PubMed ID: 1693880
[TBL] [Abstract][Full Text] [Related]
58. Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine.
Seidenfeld J; Block AL; Komar KA; Naujokas MF
Cancer Res; 1986 Jan; 46(1):47-53. PubMed ID: 3079590
[TBL] [Abstract][Full Text] [Related]
59. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.
Wallick CJ; Gamper I; Thorne M; Feith DJ; Takasaki KY; Wilson SM; Seki JA; Pegg AE; Byus CV; Bachmann AS
Oncogene; 2005 Aug; 24(36):5606-18. PubMed ID: 16007177
[TBL] [Abstract][Full Text] [Related]
60. Molecular mechanisms of polyamine analogs in cancer cells.
Huang Y; Pledgie A; Casero RA; Davidson NE
Anticancer Drugs; 2005 Mar; 16(3):229-41. PubMed ID: 15711175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
